Abvc Biopharma Inc is a biotechnology company focused on the development of innovative therapeutic solutions for various medical conditions
The company specializes in harnessing its proprietary drug development platforms to create new treatments that target unmet medical needs, particularly in areas such as cancer and neurodegenerative disorders. By combining advanced research with cutting-edge technologies, Abvc Biopharma aims to enhance patient outcomes and contribute to the evolution of healthcare through its novel pharmaceutical products.
ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical trial, registration, manufacturing, supply, and distribution rights.
Shares of Mobileye Global Inc. (NASDAQMBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
ABVC BioPharma Inc (NASDAQABVC) and its subsidiary BioLite Inc received an aggregate of 46 million shares from AiBtl BioPharma Inc as its first milestone payment under a global licensing agreement.
Shares of American Eagle Outfitters, Inc. (NYSEAEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the consensus of $1.28 billion. EPS of $0.49 surpassed the consensus of $0.48.
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 80 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.25% to 35,062.20 while the NASDAQ fell 0.54% to 14,209.12. The S&P 500 also fell, dropping, 0.31% to 4,533.28.
